Why did PHASQ stock drop so sharply today?

PHASQ stock fell due to extremely low liquidity, prior Chapter 11 restructuring history, and market notices about potential delisting. Thin volume amplified a move from the prior close of $0.000100 to $0.000001.

Is PHASQ stock likely to be delisted?

Market monitoring reports and the company’s restructuring history increase delisting risk. Delisting is not certain, but the exchange status and official filings should be watched closely for definitive signals.

What does Meyka AI forecast for PHASQ stock?

Meyka AI's forecast model currently projects a 12-month median price of $0.000000 given present data and listing uncertainty. Forecasts are model-based projections and not guarantees.

Should I buy PHASQ stock at current levels?

Current conditions show extreme risk: near-zero price, poor liquidity, and restructuring background. Investors should avoid buying without clear evidence of financing or listing resolution and should seek professional advice.

US Stocks

PHASQ PhaseBio (PNK) falls to $0.000001 on 30 Jan 2026: top loser, delisting

ByHuzaifa Zahoor January 30, 2026January 30, 2026

PHASQ stock plunged during market hours to $0.000001 on 30 Jan 2026, a -99.0% one-day change from the prior close of $0.000100. Trading volume was light at 2,500 shares versus a 50-day average of 22,310, and the quote shows a market cap effectively at $0.00 on the PNK exchange in the United States. Investors are reacting to continued restructuring and potential delisting signals; this report explains price drivers, key ratios, and what Meyka AI’s model and grade indicate for holders and traders.